Top compounds associated with response to MET


Feature Type Standardized
Nominal ANOVA
mRNA TKI258 CCLE pan-cancer AAC -0.28 2e-06
mRNA Panobinostat CCLE pan-cancer AAC -0.18 0.0004
mRNA Sorafenib CCLE pan-cancer AAC -0.2 0.0008
mRNA PD-0332991 CCLE pan-cancer AAC -0.19 0.002
mRNA Topotecan CCLE pan-cancer AAC -0.16 0.003
mRNA paclitaxel CCLE pan-cancer AAC -0.17 0.003
mRNA Nutlin-3 CCLE pan-cancer AAC -0.17 0.005
mRNA PD-0325901 CCLE pan-cancer AAC 0.1 0.06
mRNA Irinotecan CCLE pan-cancer AAC -0.13 0.07
mRNA 17-AAG CCLE pan-cancer AAC -0.096 0.1
Download CSV